Clinical Trials Logo

Allergy clinical trials

View clinical trials related to Allergy.

Filter by:

NCT ID: NCT00147940 Terminated - Allergy Clinical Trials

Correlation of Nasal Volume, Cross-Sectional Area With Nasalance Scores Measured by Acoustic Rhinometry and Nasometry

Start date: April 2004
Phase: Phase 4
Study type: Interventional

The purpose of our study is to correlate nasal volume and cross-sectional area with nasalance scores. We will measure nasal volume and cross-sectional area with acoustic rhinometry. Nasalance scores will be determined by Nasometry. Acoustic rhinometry is a means to study the volume and cross-sectional areas of the nasal cavity in a non-invasive, rapid, convenient and reliable manner. Acoustic rhinometry has the unique advantage of being completely non-invasive, and thus is able to measure nasal patency without the confounding effects of probes or invasive monitoring. Nasometry is a technique to measure the oral and nasal components of nasalance. Nasalance is the objective measure of the nasal component of speech that is determined by the ratio of sound pressure emitted from the nasal and oral cavities during speech. Nasality is the term used to characterize the nasal component of speech, and is a subjective measure. Eleven healthy subjects underwent acoustic rhinometry pre and post decongestion using oxymetazoline 0.05% nasal spray. Nasalance scores were based on the readings of three passages: rainbow, zoo, and nasal.

NCT ID: NCT00144443 Terminated - Asthma Clinical Trials

Kansas City Community Environmental Remediation And Training (KC CERT)

Start date: March 2003
Phase: N/A
Study type: Interventional

Objective: Our overall objective is to test the hypothesis that the health of children with chronic respiratory symptoms or chronic exposures to environmental hazards can be improved through a combination of standard home maintenance interventions and a set of interim controls and targeted repair interventions. I. Background: The Bi-State Kansas City Enhanced Enterprise Community (KCEEC) is one of pervasive poverty, unemployment and general distress. This same area is also an area of poor environmental health with a disproportionate number of children with lead poisoning, asthma, and home injuries. In May 2001, the Metropolitan (Kansas City) Health Council released a report urging the implementation of strategies to address this growing concern. They stated, "Environmental assessments and interventions in homes, schools, and workplaces are needed to promote indoor air quality and thereby help prevent asthma and asthma flare-ups," in combination with the need for, "trained community-based peer educators needed to work with families/communities in areas of high asthma incidence,". The need for major rehabilitation is echoed in the 1999 Consolidated Plan, as well as by most community development and housing officials. The KC CERT project responds to these concerns by demonstrating low-cost, replicable intervention strategies that can have an impact on the health and safety of children and their families. By providing training and employment opportunities to residents in high-risk areas to assess, prevent and remediate environmental hazards, this project promotes sustained systematic change within the KCEEC.

NCT ID: NCT00132847 Terminated - Asthma Clinical Trials

Comparing Allergenic Effects of 3 German Cockroach Extracts in Adults

Start date: April 2004
Phase: N/A
Study type: Observational

The purpose of this study is to test and compare the allergenic effects of three commercially available German cockroach allergen extracts in adults. Study hypothesis: The biological potency of three commercially available German cockroach allergy extracts can be compared using the ID50EAL method to standardize German cockroach allergens.

NCT ID: NCT00114881 Active, not recruiting - Asthma Clinical Trials

Urban Environmental Factors and Childhood Asthma

URECA
Start date: February 2, 2005
Phase:
Study type: Observational

Minority children who grow up in poor urban neighborhoods have the highest rates of asthma, and also experience greater morbidity from acute exacerbations of this disease. The aim of this study is to further identify environmental factors unique to the inner city that affect immune development and the expression of wheezing, atopy and asthma for purposes of identifying new strategies for asthma prevention.

NCT ID: NCT00086606 Terminated - Allergy Clinical Trials

A Safety and Efficacy Study of Xolair in Peanut Allergy

Start date: June 2004
Phase: Phase 2
Study type: Interventional

This is a 38-week, randomized, double-blind, placebo-controlled, parallel group trial of approximately 150 patients who have a history of immediate hypersensitivity reaction to peanut protein.

NCT ID: NCT00078195 Completed - Allergy Clinical Trials

Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies

Start date: April 2003
Phase: Phase 2
Study type: Interventional

A series of allergy shots may reduce symptoms of seasonal ragweed allergies. This study will determine whether taking a drug called omalizumab (also known as Xolair) before getting the allergy shots is more effective than allergy shots alone or other treatments, such as prescription antihistamines.

NCT ID: NCT00023127 Completed - Asthma Clinical Trials

Reducing Indoor Allergen Exposures in Northern Manhattan and the South Bronx

Start date: n/a
Phase: N/A
Study type: Interventional

Controlled trial of an intervention to reduce indoor exposures to cockroach allergens among asthmatic children in NYC.

NCT ID: NCT00011440 Completed - Allergic Rhinitis Clinical Trials

Pollutant Altered Allergic Responses

Start date: December 1998
Phase: N/A
Study type: Observational

This study is designed to investigate whether exposure to particulate air pollution increases the allergic response to allergens. Research studies suggest that symptoms in individuals with allergies may be aggravated by exposure to particulate air pollution. We sought to experimental determine this by exposing human volunteers to combustion particles, a component of air pollution, and then challenge them with an allergen such as ragweed or oak tree pollen. Using biological tests we can measure whether the allergen response is magnified by prior particulate exposure.